Search research articles
Contact Us
Filters
Showing results (1171-1180 of 1,218) with videos related to
Page
of 122
Sort By:
Cancer Cell
|
February 6, 2026
CCL3 is produced by aged neutrophils across cancers and promotes tumor growth
Evangelia Bolli, Pratyaksha Wirapati, Mehdi Hicham, et al.
Circulation
|
January 21, 2022
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure
Riham R E Abouleisa, Abou Bakr M Salama, Qinghui Ou, et al.
The Canadian Journal of Cardiology
|
June 13, 2008
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk
Raj S Padwal, Brenda R Hemmelgarn, Nadia A Khan, et al.
Blood
|
January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Blood
|
June 2, 2021
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
Antonio Sacco, Cinzia Federico, Katia Todoerti, et al.
Hemasphere
|
October 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Niccolò Bolli, Mattia D'Agostino, Tina Bagratuni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
The Canadian Journal of Cardiology
|
May 7, 2009
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk
Raj S Padwal, Brenda R Hemmelgarn, Nadia A Khan, et al.
Circulation Research
|
August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Ebiomedicine
|
December 19, 2023
Circulating biomarkers in familial cerebral cavernous malformation
Francesca Lazzaroni, Jennifer M T A Meessen, Ying Sun, et al.
Page
of 122
Search research articles
Search
Showing results (1171-1180 of 1,218) with videos related to
Sort By:
Page
of 122
Cancer Cell
|
February 6, 2026
CCL3 is produced by aged neutrophils across cancers and promotes tumor growth
Evangelia Bolli, Pratyaksha Wirapati, Mehdi Hicham, et al.
Circulation
|
January 21, 2022
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure
Riham R E Abouleisa, Abou Bakr M Salama, Qinghui Ou, et al.
The Canadian Journal of Cardiology
|
June 13, 2008
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk
Raj S Padwal, Brenda R Hemmelgarn, Nadia A Khan, et al.
Blood
|
January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Blood
|
June 2, 2021
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
Antonio Sacco, Cinzia Federico, Katia Todoerti, et al.
Hemasphere
|
October 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Niccolò Bolli, Mattia D'Agostino, Tina Bagratuni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
The Canadian Journal of Cardiology
|
May 7, 2009
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk
Raj S Padwal, Brenda R Hemmelgarn, Nadia A Khan, et al.
Circulation Research
|
August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Ebiomedicine
|
December 19, 2023
Circulating biomarkers in familial cerebral cavernous malformation
Francesca Lazzaroni, Jennifer M T A Meessen, Ying Sun, et al.
Page
of 122